NO964760L - MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt - Google Patents

MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt

Info

Publication number
NO964760L
NO964760L NO964760A NO964760A NO964760L NO 964760 L NO964760 L NO 964760L NO 964760 A NO964760 A NO 964760A NO 964760 A NO964760 A NO 964760A NO 964760 L NO964760 L NO 964760L
Authority
NO
Norway
Prior art keywords
msrv
pathogenic
virus
rheumatoid arthritis
strains
Prior art date
Application number
NO964760A
Other languages
English (en)
Other versions
NO964760D0 (no
Inventor
Herve Perron
Bernard Mandrand
Francois Mallet
Frederic Bedin
Frederic Beseme
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Publication of NO964760D0 publication Critical patent/NO964760D0/no
Publication of NO964760L publication Critical patent/NO964760L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Oppfinnelsen gjelder anvendelse av et viralt materiale i renset eller iso- lert tilstand, med reverstranskriptase- aktivitet, beslektet med en familie av endogene, retrovirale elementer, og/eller av et patogent og/eller infek- siøst middel i renset eller isolert tilstand som er forskjellig fra det ovenfor nevnte virale materialet, hvor begge er avledet fra en virusstamme med reverstranskriptaseaktivitet valgt blant stammene betegnet POL-2, deponert 22.07.92 hos ECACC under aksesjons- betegnelsen V92072202, henholdsvis MS7- PG, deponert 08.01.93 hos ECACC under aksesjonsbetegnelsen V93010816, og fra variantstammene av disse, som består av virus som omfatter minst ett antigen som gjenkjennes av minst ett antistoff rettet mot minst ett antigen som til- svarer ethvert av virusene fra de oven- for nevnte virusstammer POL-2 og MS7PG, for å fremstille et diagnostisk, profy- laktisk eller terapeutisk preparat for påvisning, forebyggelse eller behand- ling av en infeksjon av dette virale materialet og/eller patogene og/eller infeksiøse middel, forbundet med reumatoid artritt.
NO964760A 1995-03-09 1996-11-08 MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt NO964760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9502960A FR2731356B1 (fr) 1995-03-09 1995-03-09 Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide
PCT/FR1996/000360 WO1996028552A1 (fr) 1995-03-09 1996-03-07 Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide

Publications (2)

Publication Number Publication Date
NO964760D0 NO964760D0 (no) 1996-11-08
NO964760L true NO964760L (no) 1996-11-08

Family

ID=9477022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964760A NO964760L (no) 1995-03-09 1996-11-08 MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt

Country Status (11)

Country Link
EP (1) EP0731168A1 (no)
JP (1) JPH08322579A (no)
AU (1) AU5007396A (no)
BR (1) BR9605926A (no)
CA (1) CA2171242A1 (no)
CZ (1) CZ328796A3 (no)
FR (1) FR2731356B1 (no)
NO (1) NO964760L (no)
NZ (1) NZ303694A (no)
PL (1) PL317200A1 (no)
WO (1) WO1996028552A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737500B1 (fr) * 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
JP4226657B2 (ja) * 1996-11-26 2009-02-18 ベーイーオー メリュー 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片
FR2765588A1 (fr) 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
JP4249269B2 (ja) * 1997-07-07 2009-04-02 ベーイーオー・メリュー 自己免疫疾患および／または妊娠障害に関連する内因性レトロウイルス配列
FR2788784A1 (fr) * 1999-01-21 2000-07-28 Bio Merieux Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
ES2233936T3 (es) * 1994-02-04 2005-06-16 Bio Merieux Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones.

Also Published As

Publication number Publication date
EP0731168A1 (fr) 1996-09-11
NO964760D0 (no) 1996-11-08
PL317200A1 (en) 1997-03-17
FR2731356A1 (fr) 1996-09-13
CA2171242A1 (fr) 1996-09-10
WO1996028552A1 (fr) 1996-09-19
FR2731356B1 (fr) 1997-04-30
NZ303694A (en) 1997-11-24
CZ328796A3 (en) 1997-03-12
AU5007396A (en) 1996-10-02
BR9605926A (pt) 1997-09-02
JPH08322579A (ja) 1996-12-10

Similar Documents

Publication Publication Date Title
BHAT et al. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275
NO953925L (no) MSRV1-virus og MSRV2-patogent og/eller infeksiöst middel forbundet med multippel sklerose, nukleinsyrekomponenter og anvendelse av disse
CA2073031A1 (en) Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
KR950032278A (ko) 사람 면역결핍 바이러스 그룹의 레트로바이러스로부터 유래된 펩타이드 및 이의 용도
US5550052A (en) Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells
AU1225088A (en) Peptides having immunological properties 2-hiv-2
WO1996012809A3 (fr) Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
DE3855134T2 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE309365T1 (de) Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen
GB9016315D0 (en) Medicaments
NO964760L (no) MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt
Sherefa et al. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis
ATE159983T1 (de) Monoklonaler antikörper gegen htlv-iii (stamm mn)
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
JP2008156350A (ja) Ｈｉｖ−２型ヒトレトロウイルスのトランスメンブランエンベロープ糖タンパク質の抗原、及び、該抗原に免疫類似性を有する抗原
Gerenčer et al. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients
CA2109961A1 (en) Peptides for use in induction of t cell activation against hiv-1
SU1768637A1 (en) Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
EP0250128A3 (en) Novel virus isolated from patients with aids
Bose et al. Seroepidemiological investigations on human immunodeficiency virus infections in some parts of India
Zhang et al. Human T Lymphotropic Virus Types 1-and II-Specific Antibody-Dependent Cellular Cytotoxicity: Strain Specificity and Epitope Mapping
WO1991018618A3 (en) Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
EP0400245B1 (en) Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies directed against them - application for the diagnosis